These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6290853

  • 1. Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV.
    Sugamura K, Tanaka Y, Hinuma Y.
    Microbiol Immunol; 1982; 26(7):575-83. PubMed ID: 6290853
    [Abstract] [Full Text] [Related]

  • 2. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y, Sugamura K, Hinuma Y.
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [Abstract] [Full Text] [Related]

  • 4. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells.
    Lakhdar M, Senik A, Fridman WH.
    Cell Immunol; 1984 Feb; 83(2):414-21. PubMed ID: 6198104
    [Abstract] [Full Text] [Related]

  • 6. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
    Sugamura K, Tanaka Y, Hinuma Y.
    Int J Cancer; 1981 Aug 15; 28(2):137-42. PubMed ID: 6274810
    [Abstract] [Full Text] [Related]

  • 7. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 15; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 8. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul 15; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 9. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S, Masucci MG, Szigeti R, Bishara A, Brautbar C, Klein G, Klein E.
    Mol Biol Med; 1984 Aug 15; 2(4):285-99. PubMed ID: 6443579
    [Abstract] [Full Text] [Related]

  • 10. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M, Fridman WH, Tursz T, Vincent C, Pious D, Fellous M.
    J Exp Med; 1979 Dec 01; 150(6):1310-22. PubMed ID: 229186
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 01; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
    Tanaka Y, Sugamura K, Hinuma Y, Sato H, Okochi K.
    J Immunol; 1980 Oct 01; 125(4):1426-31. PubMed ID: 6157733
    [Abstract] [Full Text] [Related]

  • 14. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan 01; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
    Fresen KO, Hausen H.
    Int J Cancer; 1976 Feb 15; 17(2):161-6. PubMed ID: 175026
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1).
    Duncombe AS, Grundy JE, Oblakowski P, Prentice HG, Gottlieb DJ, Roy DM, Reittie JE, Bello-Fernandez C, Hoffbrand AV, Brenner MK.
    Blood; 1992 Jun 01; 79(11):3059-66. PubMed ID: 1316791
    [Abstract] [Full Text] [Related]

  • 18. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
    Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y.
    J Immunol; 1983 Jun 01; 130(6):2942-6. PubMed ID: 6189906
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing the human cytotoxic T cell response to autologous lymphoblastoid cell lines in vitro.
    Misko IS, Soszynski TD, Kane RG, Pope JH.
    Clin Immunol Immunopathol; 1984 Sep 01; 32(3):285-97. PubMed ID: 6088142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.